Ou se connecter avec
Twitter Twitter
Facebook Facebook
Apple Apple     
Ou se connecter avec
Twitter Twitter
Facebook Facebook
Apple Apple     
  1. Accueil Zonebourse
  2. Actions
  3. France
  4. Euronext Paris
  5. Novacyt
  6. Actualités
  7. Autres langues
    ALNOV   FR0010397232


Temps réel Euronext Paris  -  17:35 30/11/2022
0.8300 EUR   +15.41%
10/11Novacyt : départ du directeur général
10/11Le PDG de la société de biotechnologie Novacyt démissionne, un PDG intérimaire est nommé
10/11Novacyt annonce le retrait de David Allmond en tant que membre du Conseil d'administration
SynthèseToute l'actualitéReco analystesAutres languesCommuniquésPublications officiellesActualités du secteurAnalyses Zonebourse
Actualités dans d'autres langues sur NOVACYT
10/11Biotechnology Company Novacyt CEO Steps Down, Interim CEO Named
10/11Novacyt Announces Step Down of David Allmond as Member of the Board
10/11Novacyt Announces Executive Changes
08/11Novacyt : RUO Portfolio Product Update
26/10TRADING UPDATES: Novacyt wins UK approval; React outlook confident
26/10Novacyt Gets UK Nod For New COVID-19 PCR Test
26/10Bolsa de Madrid: Don't fight the Fed
26/10Novacyt Announces Approval of genesig® SARS-CoV-2 Winterplex® 3 Gene Assay Panel in the..
10/10Novacyt Faces $150 Million Legal Claim For Inconsistent COVID-19 Testing Results In UK
04/10Novacyt : Contrat de liquidité
04/10Novacyt : Liquidity Agreement
29/09Transcript : Novacyt S.A., H1 2022 Earnings Call, Sep 29, 2022
29/09Novacyt : Investor Presentation September 2022
29/09Earnings Flash (NCYT.L) NOVACYT Posts H1 Revenue GBP16.5M
29/09Earnings Flash (NCYT.L) NOVACYT Reports H1 Loss GBP-0.07
29/09Earnings Flash (NCYT.L) NOVACYT S.A. Posts H1 Revenue GBP16.5M
29/09Novacyt S.A. Reports Earnings Results for the Half Year Ended June 30, 2022
29/09Novacyt S.A. Provides Group Financial Guidance for the Third Quarter and Year-To-Date E..
16/09Roquefort Therapeutics Names CEO, Chief Scientific Officer
15/09Bolsa de Madrid: El mercado se pone las pilas
04/08Novacyt Launches First Fully Lyophilized Direct-to-PCR Assays; Shares Up 5%
04/08Bolsa de Madrid: La tecnología está cansada de ir cuesta abajo
04/08Novacyt Announces the Launch of the First Fully Lyophilised (Freeze-Dried), Direct-To-P..
28/07Novacyt Creates Research-use-only Adenovirus F41 Test Kit Amid Rising Hepatitis Cases
28/07Novacyt S.A. Launches Research-Use-Only Adenovirus F41 Assay
21/07Novacyt : Results of Annual General Meeting
21/07Novacyt : AGM Investor Presentation
15/07Novacyt - Approval of exsig COVID-19 Direct test in the UK under CTDA legislation
15/07Bolsa de Madrid: China en el centro de la escena
15/07UK Watchdog OKs Novacyt's exsig COVID-19 Direct Test
15/07Novacyt S.A. Announces Approval of exsig COVID-19 Direct test in the UK
07/07Actualización de las fuertes variaciones del día: D..
28/06France's Novacyt Rolls Out Monkeypox Assay
28/06Novacyt Announces the Launch of Its Research-Use-Only Polymerase Chain Reaction Monkeyp..
20/06Novacyt : Convening notice for 21st June 2022
20/06Novacyt : Proxy voting form for 21st June 2022
16/06Novacyt Files Counterclaim Against UK Department of Health and Social Care
01/06Novacyt's COVID-19 PCR Test Wins UK Approval
01/06Novacyt S.a. (“novacyt”, : Publication of Annual Report and AGM voting
31/05Novacyt : Text of the resolutions
28/04Novacyt : 2021 Management Report
28/04Novacyt 1Q Covid-19-Related Revenue Fell; Sees 2023 Revenue Fall if Trend Continues
28/04Novacyt S.a. ("novacyt", The "compan : Full year 2021 results and update on growth strateg..
28/04Novacyt S.A. Reports Earnings Results for the Full Year Ended December 31, 2021
28/04Novacyt Seeks Acquisitions
26/04Novacyt Slumps 13% on UK Health Agency's $172 Million Claim in COVID-19 Test Contract D..
26/04Novacyt To Oppose UK Health Agency's $172 Million Claim In COVID-19 Test Contract Dispu..
20/04Novacyt : Notice of Full Year 2021 Results and Investor Presentation
12/04Novacyt's COVID-19 PCR Test Gets UK Approval
12/04Novacyt Announces Approval of COVID-19 Test Under CTDA Legislation
17/02Novacyt's Direct-To-PCR COVID-19 Test Secures British Approval
17/02Novacyt S.A. Gets Approval of the First Direct-to-PCR COVID-19 Test in the UK Under CTD..
17/02Novacyt S.A. Announces Approval of the First Direct-To-PCR Covid-19 Test in the UK Unde..
04/02Novacyt : Long Term Incentive Plan 2022 Performance Share Awards
25/01FTSE 100 to Gain After Wall Street Closes Higher
2021EUROPEAN MIDDAY BRIEFING - Stocks, Oil Drop on Concerns Over New Covid-19 Variant
2021EUROPEAN MIDDAY BRIEFING - Stocks, Oil Drop on -2-
2021Novacyt Secures UK Nod For COVID-19 Test
2021Novacyt Flags Revenue Hit as UK Regulator Clears Only Two COVID-19 Tests
2021BP's Underlying Results Seen as Decent
2021Dos fabricantes retiran sus pruebas de COVID tras una nueva revisión de Reino Unido
2021FTSE 100 Falls in Early Trade; Flutter, BP Slide
2021London Stocks Seen Opening Lower; BP in Focus
2021Novacyt S.A. Announces Validation of Covid-19 Tests in the UK Under CTDA Legislation
2021Novacyt : Results of Annual General Meeting
2021Novacyt : 2021 agm
2021Novacyt : Convening notice for 18th October 2021
2021Novacyt : Launches Two New PCR Tests for COVID-19, Other Winter Viruses
2021Novacyt : R&D update
2021Novacyt S.A.(ENXTPA:ALNOV) dropped from Next Biotech Index
2021Novacyt : Notice of AGM
2021Novacyt : 2021 agm
2021Novacyt : Notice of rescheduled AGM
2021Global markets live: Intel, Apple, Rolls-Royce, Raytheon, MGM...
2021Novacyt : Interim Accounts June 2021
2021Novacyt : Rapport D'Activitie Semestriel 2021
2021FTSE 100 Seen Opening Higher
2021Novacyt : Half year 2021 results
2021Novacyt : Earnings Flash (NCYT.L) NOVACYT Posts H1 Loss GBP-0.18
2021Novacyt : Earnings Flash (NCYT.L) NOVACYT S.A. Reports H1 Revenue GBP54M
2021L'agenda di oggi
2021L'agenda della settimana
2021L'agenda della prossima settimana
2021FTSE 100 Rises on Speculation over UK's Travel Restrictions Removal
2021Global markets live: Thales, Nestlé, Evergrande, AMC, Walmart...
2021FTSE Rises, THG Shares Fall After 1st Half Loss as Shake-Up Looms
2021Novacyt : Dispute With UK Health Department Threatens To Wipe Out H1 Profit
2021FTSE Rises, Ashtead Gains After 1Q Profit Boost, Guidance Increase
2021Novacyt Says Covid-19 Contract Dispute with UK Health Department Continues
2021Novacyt to Revise Down 1st Half Revenue Due to UK Covid-19 Contract Dispute -- Update
2021Novacyt : Proposed accounting treatment of ongoing DHSC dispute in 2021 interim results
2021Novacyt : AGM voting
2021Novacyt : Company's activity during FY20
2021Novacyt : 2021 half year revenues
2021FTSE 100 Slips 0.2%, Dragged by BHP
2021Pound Likely to Rise Vs Euro on UK Economic Outperformance
2021U.K. Inflation Expected to Rise Sharply After July's Dip
2021FTSE 100 to Open Higher as Traders Digest Latest Inflation Data
2021Novacyt : Half Year Update
2021Novacyt S.A. Reiterate Revenue Guidance for the Full Year 2021